Heidelberg Epignostix GmbH https://validator.w3.org/feed/docs/rss2.html Product fact sheets Contact Form News Terms of Use Terms of Use (archived) Epignostix announces CMS release of a preliminary gapfill price for their proprietary CPT Code for the Epignostix CNS Tumor Methylation Classifier test Team Epignostix launches advanced DNA methylation-based sarcoma classifier About Us Our technology Sarcoma methylation classifier Heidelberg Epignostix is live! Profile DKFZ spin-off Epignostix raises €4.3m seed round to commercialize diagnostic tumor classifier Heidelberg Epignostix appoints Helge Lubenow as CEO  Legal notice Change Password Reset Password Forgot Password? Login Register Users List Item Account Epignostix launches CNS and sarcoma diagnostic tumor classifier applications Privacy policy Disclaimer Contact us Register your interest Video Tutorial FAQs CNS tumor methylation classifier Cookie Policy (EU)